GT Biopharma, Inc. (GTBP) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-6.68 | +3.7% |
| 2024 | $-6.94 | -23.0% |
| 2023 | $-5.64 | +71.3% |
| 2022 | $-19.66 | -854.4% |
| 2021 | $-2.06 | — |
| 2018 | $-5.16 | +40.0% |
| 2017 | $-8.60 | -107.2% |
| 2016 | $119.91 | +1438.3% |
| 2015 | $-8.96 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-6.68 | +3.7% |
| 2024 | $-6.94 | -23.0% |
| 2023 | $-5.64 | +71.3% |
| 2022 | $-19.66 | -854.4% |
| 2021 | $-2.06 | — |
| 2018 | $-5.16 | +40.0% |
| 2017 | $-8.60 | -107.2% |
| 2016 | $119.91 | +1438.3% |
| 2015 | $-8.96 | — |